₹564.45
▼ -0.9 -0.16%
As of 28 Jul 2026 · delayed
NSE Listed · Pharmaceuticals
Jeena Sikho Lifecare Ltd. (JSLL)
Volume: 5,81,139Avg Vol 1W: 4,48,445Avg Vol 1M: 4,71,56652W Range:₹492₹849.5
Key Ratios
Checked just nowMarket Cap₹7,016 Cr
Current Price₹564.45
Previous Close₹565.35
High / Low (52w)₹849.5 / ₹492
Volume5,81,139
Avg Vol (1W)4,48,445
Avg Vol (1M)4,71,566
Stock P/E155.5
Book Value₹37.58
Dividend Yield0.74%
ROE47.5%
ROA32.88%
Revenue (TTM)—
Revenue Growth39.71%
Profit Margin27.68%
Total Debt₹53,95,000 Cr
Shares Outstanding12 Cr
Face Value₹2
EPS (TTM)₹3.63
P/B15.02
Debt / Equity0.27
50 DMA₹593.85
200 DMA₹665.12
Day change-0.16%
Price Chart
₹564.45▲ 1.67% · 1Y
2025-07-292026-07-28
20-day avg volume: 4.5L shares
Pros
- Healthy return on equity of 47.5%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 156.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹100 Cr | ₹114 Cr | ₹116 Cr | ₹139 Cr | ₹174 Cr | ₹190 Cr | ₹222 Cr | ₹216 Cr |
| EBITDA | ₹22 Cr | ₹37 Cr | ₹22 Cr | ₹37 Cr | ₹70 Cr | ₹83 Cr | ₹92 Cr | ₹65 Cr |
| Net Profit | ₹16 Cr | ₹27 Cr | ₹13 Cr | ₹25 Cr | ₹51 Cr | ₹59 Cr | ₹67 Cr | ₹45 Cr |
| EPS | 1.3 | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹100 Cr | ₹114 Cr | ₹116 Cr | ₹139 Cr | ₹174 Cr | ₹190 Cr | ₹222 Cr | ₹216 Cr |
| EBITDA | ₹22 Cr | ₹37 Cr | ₹22 Cr | ₹37 Cr | ₹70 Cr | ₹83 Cr | ₹92 Cr | ₹65 Cr |
| Net Profit | ₹16 Cr | ₹27 Cr | ₹13 Cr | ₹25 Cr | ₹51 Cr | ₹59 Cr | ₹67 Cr | ₹45 Cr |
| EPS | — | — | — | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Total Assets | ₹38 Cr | ₹49 Cr | ₹62 Cr | ₹151 Cr |
| Total Liabilities | ₹24 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
| Equity | ₹14 Cr | ₹24 Cr | ₹36 Cr | ₹126 Cr |
| Total Debt | ₹0 Cr | ₹0 Cr | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Operating | ₹21 Cr | ₹20 Cr | ₹23 Cr |
| Investing | ₹-8 Cr | ₹-18 Cr | ₹-33 Cr |
| Financing | ₹-2 Cr | ₹-5 Cr | ₹48 Cr |
| Free Cash Flow | ₹21 Cr | ₹15 Cr | ₹22 Cr |
Shareholding
Promoter 63.62% Institutions 5.14% Public 31.24%
Efficiency & Working Capital
ROCE52.1%
Interest Coverage47.6
Dividend Payout—
Debtor Days39 d
Inventory Days7 d
Payable Days11 d
Cash Conversion Cycle36 d
Working Capital Days47 d
Shareholding Details
As of 2026-06-30
Promoter63.6%
FII4.8%
DII0.4%
Institutions5.1%
Public31.2%
Promoter Pledge0%
No. of Shareholders43,413
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Nov 2023 | Nov 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 67.9% | 67.9% | 67.9% | 65.8% | 63.5% | 63.5% | 63.5% | 63.5% | 63.6% | 63.6% | 63.6% | 63.6% |
| FIIs | 1.8% | 1.8% | 0.3% | 4% | 6% | 5.9% | 6% | 6% | 6.6% | 6.3% | 6.2% | 4.8% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0.2% | 0.2% | 0.2% | 0.1% | 0.5% | 0.4% |
| Public | 30.3% | 30.3% | 31.8% | 30.1% | 30.5% | 30.6% | 30.3% | 30.3% | 29.7% | 30% | 29.8% | 31.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,107 | 1,107 | 2,721 | 3,423 | 5,967 | 6,603 | 7,482 | 7,482 | 16,362 | 22,181 | 25,905 | 43,413 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Manish Grover | Shareholding of Promoter and Promoter Group | 63.3% | 7.86 Cr |
| Sixteenth Street Asian Gems Fund | Public Shareholding | 4.2% | 52,19,863 |
| Oregano Life Private Limited | Public Shareholding | 3% | 36,67,913 |
| Ajay Kumar Aggarwal | Public Shareholding | 1.7% | 20,83,165 |
| Bhavna Grover | Shareholding of Promoter and Promoter Group | 0.2% | 2,43,000 |
| Rohit Grover | Shareholding of Promoter and Promoter Group | 0.1% | 76,191 |
| Mukesh Grover | Shareholding of Promoter and Promoter Group | 0% | 52,740 |
| Santosh Grover | Shareholding of Promoter and Promoter Group | 0% | 30,461 |
| Sahil Jain | Shareholding of Promoter and Promoter Group | 0% | 17,191 |
| Shreya Grover | Shareholding of Promoter and Promoter Group | 0% | 8,190 |
| Akansha Jain | Shareholding of Promoter and Promoter Group | 0% | 8,190 |
| Ashish Grover | Shareholding of Promoter and Promoter Group | 0% | 3,495 |
| Madhav Grover | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sunil Khurana | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Som Khurana | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Premkanta Kapoor | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sunita Uppal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Manish Grover (huf) | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Manish Grover | Chairman & Managing Director | 2025 |
| Bhavna Grover | WTD & Executive Director | 2025 |
| Karan Vir Bindra | Independent Non Exe. Director | 2025 |
| Shreya Grover | Whole-time Director | 2025 |
| Chandan Kumar Kaushal | Independent Non Exe. Director | 2025 |
| Priyanka Bansal | Independent Non Exe. Director | 2025 |
| Smita Chaturvedi | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Trading of Ayurvedic Medicines and | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 25 | 25 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-22 | ₹1.1 (55%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 14 | 7 | 22 |
| 2025 | 0 | 0 | 0 | 10 | 0 | 10 |
| 2025 | 0 | 0 | 0 | 4 | 0 | 5 |
Company Information
Incorporated2017
ChairmanManish Grover
AuditorKRA & Co/Walker Chandiok & Co LLP
Investor Email[email protected]
📍 SCO 11 First Floor Kalgidhar, Enclave Zirakpur, Mohali, Punjab, 140604
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search